Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate

Authors

  • Kambiz Novin Department of Radiotherapy and Oncology, Haft-e-Tir Hospital, Faculty of Medicine, Iran University of Medical Sciences
  • Nafiseh Mortazavi

Keywords:

Biosimilar Bevacizumab

Abstract

No Abstract

Downloads

Published

2019-03-17

How to Cite

Novin, K., & Mortazavi, N. (2019). Methodological Consideration for Clinical Development of Bevacizumab Biosimilar Candidate. Reports of Radiotherapy and Oncology, 5(1), 1–2. Retrieved from https://waocp.com/journal/index.php/Reports-of-Radiotherapy-and-Onco/article/view/2319

Issue

Vol. 5 No. 1 (2018)

Section

Articles